MOESM2 of Closed system RT-qPCR as a potential companion diagnostic test for immunotherapy outcome in metastatic melanoma
2019-09-19T04:09:06Z (GMT) by
Additional file 2: Figure S2. RECIST category of objective response rate and multiplex RT-qPCR immunotherapy panel markers. (A) CD274, PDCD1LG2, CD8A, and IRF1 transcript expression. Data are presented as mean with standard deviation (error bars). (B) Predictive performance of CD274, PDCD1LG2, CD8A, and IRF1 transcript expression by ROC curves.